Board Pack
Q1 Board Pack — Intelligence Summary
Portfolio & market overview
- Author
- A. Analyst (sample)
- Date
- 2025-02-20
- Version
- v1.2
- Status
- Final
- Confidence
- High
Executive Summary
The quarter's decisions centered on AI-infrastructure exposure. The portfolio benefited from the compute cycle; the board's attention should focus on concentration and supply resilience across holdings.
What changed
Compute-cycle exposure drove performance this quarter.
Why
Demand strength across AI-infrastructure names.
Who is affected
Portfolio construction and risk posture.
Evidence
Holdings review and market notes.
Next decision
Decide risk posture for next quarter.
Key Findings
- 1
Compute exposure paid off
PositiveAI-infrastructure holdings led returns.
- 2
Concentration building
WatchExposure is clustering in a few themes.
- 3
Supply resilience unclear
RiskCross-holding supply dependence needs review.
Evidence
| Claim | Source | Type | Confidence | Date |
|---|---|---|---|---|
| Sector led performance | Industry note | Research | Medium | 2025-01-30 |
Sources
Company filing (FY24)
Sample filing
Filing2025-02-18Earnings call transcript
Investor relations
Transcript2025-02-19Industry note
Sample research
Research2025-01-30
Risks
- Theme concentrationL: Medium · I: HighDiversification is thinning.
- Correlated supply riskL: Medium · I: MediumHoldings share suppliers.
Opportunities
- Rebalance — Trim winners, add under-covered layers.
Assumptions
- No regime change in rates or demand this quarter.
Open Questions
- What concentration limit is acceptable?
Recommendations
Set a theme-concentration limit
High priorityProtect against clustered drawdowns.
Owner: Board
Decision Log
| Date | Decision | Owner | Outcome |
|---|---|---|---|
| 2025-02-20 | Adopt concentration guardrail | Board | Approved |
Appendix
Methodology
Sample methodology note — how findings would be assembled and scored.
Glossary
Definitions of terms used throughout the report.
Version History
- v1.22025-02-20A. Analyst (sample)Refined recommendations after review.
- v1.12025-02-12A. Analyst (sample)Added evidence and risk matrix.
- v1.02025-02-05A. Analyst (sample)Initial draft.